Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S7W-04082 · Session 7

What interim measures can be taken regarding the prescription of Bedrolite to children with severe forms of epilepsy pending completion of …

Answered Asked by Martyn Day SNP Lodged 7 Oct 2026

The question

To ask the Scottish Government what interim measures can be taken regarding the prescription of Bedrolite to children with severe forms of epilepsy pending completion of the National Institute for Health and Care Research clinical trial in July 2029.

The answer

Answered by Maree Todd on 3 Nov 2026 · 27 days after it was lodged, on time

Bedrolite is an unlicenced cannabis-based medicine.For any cannabis-based medicines to be prescribed for use in the NHS in Scotland, as with any other unlicensed medicine, clinical trials are essential to ensure that they are proven safe and effective before they can be considered for a licence and for a wider routine availability.The Scottish Government continues to support the development of UK-based clinical trials which will help to build the evidence base for cannabis-based medicines.

In the Official Report

No contribution in the Official Report cites S7W-04082 by reference.